Quantcast

Wrap Up

First Half of 2014 Best for M&A in 3 Years
Positive predictions for 2014 are coming true, with the first six months of the year generating more deals than the same periods in 2012 and 2013

People Moves of the Week

BTIG, D.A. Davidson, KeyBanc
BTIG taps two former Lazard execs; D.A. Davidson launches real estate team; KeyBanc drafts Anne-Marie Peterson to the firm's leveraged finance team

REAL ESTATE

BET Founder Continues Picking Up Hotels
RLJ Lodging, founded by Robert L. Johnson, recently paid about $50M for an Atlanta Hyatt

Digital Edition

VIEW DIGITAL EDITION »

Fund of Funds, Lender

ESOP, Recapitalization

Agriculture, Natural Resources

New York, Hong Kong

Northeast US, Asia/Pacific

United States, Canada

 

People Database

Exclusive data on top players in capital markets

Sylvie Gadant

Partner

Firm: Citrin Cooperman

In the news: People Moves of the Week: Barclays, Bryan Cave, Mayer Brown

SEARCH PEOPLE DATABASE »

references

Health Care

News

Turnaround Tuesday: Struggling Drug Developer Zogenix Wins Massachusetts Lawsuit


The company won the right to sell painkiller Zohydro in Massachusetts, and plans to develop an abuse-deterrent variation of the drug

The Weekly Wrap: Lindt Chocolate, InterActiveCorp, Platinum Equity


Lindt buys Russel Stover; InterActiveCorp picks up HowAboutWe.com; Platinum Equity acquires Transworld Systems

AbbVie to Buy Shire for $54.8 Billion in Tax Inversion


AbbVie becomes the latest U.S. health company to move abroad amid a record surge in industry deals

Thoma Bravo Acquires PE-Backed Sparta Systems


The move comes after the PE firm closed a $3.65B fund in May

Helen of Troy Expands into Supplements with $195M Deal


The owner of Pur, Braun and Vicks is buying Healthy Directions

more »

Articles

3Qs With... Craig Jarchow, Managing Director, Pine Brook Partners


As the energy sector needs more capital, PE firms have been raising energy-specific funds

Lucid Explores Options, Looks for PE Investment


The company makes cellular imaging systems for dermatologists

Q3: Middle-Market M&A Turns Down a Notch


While a global tally shows a slight uptick, U.S. deals below $1 billion still lag

5. Valeant Pharmaceuticals


The company fills existing distribution channels with additional products or buys similar operations to exploit synergies

4. Health Care REIT


Under the guidance of executive VP Scott Brinker, HCN took note of the deal opportunities arising from an aging populace

more »